Clay Siegall is one of a lucky minority of people who realize early on in their lives what they want to achieve in their careers. While many people look for something to totally capture their interests, Clay Siegall and others like him know what they want to achieve. In the case of Siegall, he began his undergraduate studies in Zoology at the University of Maryland. When he was accepted for post-graduate doctoral work at George Washington University, his choice of Genetics was firmly established in his mind.
Siegall’s career has followed this single and straight line towards ridding the world of the most feared disease on the planet, cancer. He has worked for and with National Institutes of Health, The National Cancer Center, and Bristol-Myers Squibb Pharmaceutical Research. In 1998 He founded his company, Seattle Genetics, and continues working to achieve his goals on a daily basis.
Dr. Clay Siegall has also received numerous industry awards, including the prestigious 2013 University of Maryland Alumnus Award and the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year Award. He sits on the boards of Ultragenyx Pharmaceutical, Alder BioPharmaceuticals and Washington Roundtable.
Siegall holds 15 patents and has authored more than 70 individual publications.
Clay Siegall has recently started a blog as a way to invite more of the public into his life-saving world. He is building his website from a collection of interesting National Public Radio broadcasts. Enjoy NPR now because under the new Trump Administration, NPR, National Public Radio will lose its funding and may cease to exist. Undaunted by these distractions Siegall will continue to do his research work and might be the scientist to open the door to a new world free from the scourges of cancers.